Biotech Risk Mitigation
Typical biotech investment presentations often suffer from human cognitive biases, leading to flawed conclusions, contributing to a 90% failure rate in clinical drug development.
Drug discovery needs a radical shift to match the urgency, innovation, and precision required to deliver tomorrow’s therapies. Imagine Biotech is leading that transformation — harnessing advanced AI, predictive modeling, and data-rich simulation to accelerate and de-risk development. With deep scientific insight at our core, our mission is clear: reshape your drug journey and bring breakthrough molecules to life.
Pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition
Know Your Molecule
Imagine Biotech " Know Your Molecule™"
Biotech researchers are likely aware but not familiar of many cutting-edge molecular study technologies, but it would be an overstatement to say they know all the latest technologies.
Approximately 30% of drug failures in clinical trials are due to unmanageable toxicity.
The field is rapidly evolving, and the Imagine Biotech experts are on the forefront of the ability to de-risk the technology.
FDA | AnimalGAN Capabilities
AnimalGAN and Digital Animal Replacement Technology (DART) use historical data and human biology to simulate animal responses, minimizing the need for new animal tests.
Our AnimalGAN capabilities, powered by generative adversarial networks (GANs), outperforms standard QSAR models by generating comprehensive toxicology profiles with greater accuracy and efficiency.
It excels at detecting rare toxicological events through unlimited virtual experiments
Our Services
1
Know Your Molecule™
Know Your Molecule™ applies advanced computational chemistry, structural analysis, and bioinformatics to uncover molecular red flags, validate mechanisms of action, and predict toxicity — enabling smarter, faster drug development decisions.
Approximately 30% of drug failures in clinical trials are due to unmanageable toxicity.
2
ADMET Prediction & PK Modeling
ADMET and PK package for early detection of formulation challenges, integrating molecular data with physiological insights. AI in Drug Toxicity Prediction reduces late-stage failures, using six toxicity properties and Tox21 endpoints. We use about 40 quantum chemistry programs, including DFT packs.
3
Precision Solubility Screening
Solubilization is the critical first step in drug development, where intelligent, AI-driven modeling replaces costly trial-and-error to identify optimal excipients, enhance bioavailability, and accelerate formulation — all while saving millions in time and resources.
4
Molecular Docking/Pre-clinical Toxicology Reports
We use open-source AI/ML models, databases, and docking software for biotech due diligence. With over 80 docking tools, we analyze 3D structures of APIs with target proteins, using resources like NCBI Clinvar. We utilize AlphaFold3, Rosetta Commons, and quantum simulations for detailed structural analysis.
5
CMC Advisory and Consulting
Developing an IND application is a major milestone. Often, the CMC aspect is overlooked until too late, causing 40% of clinical holds. Ensuring drug quality, safety, and efficacy. Covering all aspects of drug development, from initial design through manufacturing, to ensure consistent quality and compliance.
6
Expert Technology Capabilities
Cutting edge of scientifc and technical due diligence. Our team offers:
-
Mass Spectrometry Assets
-
Nuclear Magnetic Resonance (NMR) Spectroscopy
-
Chromatography Techniques
-
Bioinformatics and Data Analysis Tools
-
Metabolite Databases
-
Fluxomics Tools